Methods: Surveys were administered to HIV providers in Miami, Florida and Washington,
District of Columbia. Composite scores were developed to measure PrEP knowledge …

Objectives As trials were assessing the safety and efficacy of daily oral antiretroviral
preexposure prophylaxis (PrEP) for the prevention of HIV infection, there was a clear need to …

Background: Expanding access to HIV preexposure prophylaxis (PrEP) could help reduce
rates of HIV infection in the United States. This study characterizes activities and barriers to …

Increasing prescription of pre-exposure prophylaxis (PrEP) is imperative to ending the HIV
epidemic in the United States. The objective of this review was to identify health care …

HIV pre-exposure prophylaxis (PrEP) was FDA approved in 2012, but uptake remains low.
To characterize what would facilitate health care providers' increased PrEP prescribing, we …

Pre-exposure prophylaxis (PrEP) is an effective HIV prevention method, but many primary
care physicians (PCPs) have not incorporated PrEP into practice. While PrEP may be a key …

Background: The HIV epidemic among black men who have sex with men (BMSM) demands
urgent public health attention. Pre-exposure prophylaxis (PrEP) is a highly efficacious option …

Background: Preexposure prophylaxis (PrEP) discontinuation rates in clinical trials and
demonstration projects have been well characterized; however, little is known about …

Background: The aim of this study was to evaluate the efficacy of a novel, brief 2-session
behavioral intervention to promote HIV pre-exposure prophylaxis (PrEP) uptake among men …

Background: HIV incidence among US young, black men who have sex with men (YBMSM)
is high, and structural barriers (eg lack of health insurance) may limit access to Pre-exposure …